Literature DB >> 2984412

H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system.

K Inui, M Takano, T Okano, R Hori.   

Abstract

The transport of aminocephalosporin antibiotics such as cephalexin, zwitterion, by rat renal brush border membrane vesicles has been studied in relation to the transport system of organic cation. Cephalexin uptake was inhibited by organic cations such as tetraethylammonium, 1N-methylnicotinamide and choline, whereas cefazolin uptake was not. Tetraethylammonium uptake was inhibited by aminocephalosporins and stimulated by the countertransport effect of cephalexin. In agreement with the transport mechanisms of organic cation, the presence of an H+ gradient ([H+]i greater than [H+]o) induced a marked stimulation of aminocephalosporin uptake, and this uptake was inhibited by HgCl2 and tetraethylammonium. These results suggest that aminocephalosporins can share a common carrier transport system with organic cation in renal brush border membranes, and this system could be a part of the mechanisms of tubular secretion for aminocephalosporins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984412

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.

Authors:  Kunio Fujiwara; Masashi Shin; Yohei Yoshizaki; Tsubasa Miyazaki; Tetsuya Saita
Journal:  J Mol Histol       Date:  2011-10-18       Impact factor: 2.611

2.  Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates.

Authors:  S Dautrey; K Felice; A Petiet; B Lacour; C Carbon; R Farinotti
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Transport mechanism of ceftibuten, a dianionic cephem, in rat renal brush-border membrane.

Authors:  I Naasani; M Sugawara; M Kobayashi; K Iseki; K Miyazaki
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 4.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

Review 5.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carboxylates; nonionizable substrates: steroid hormones and cyclophosphamides.

Authors:  K J Ullrich; G Rumrich; C David; G Fritzsch
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

7.  Expression and protein kinase C-dependent regulation of peptide/H+ co-transport system in the Caco-2 human colon carcinoma cell line.

Authors:  M Brandsch; Y Miyamoto; V Ganapathy; F H Leibach
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

8.  Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys.

Authors:  C A Rodriguez; D E Smith
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Expression of renal organic cation transporter in Xenopus laevis oocytes.

Authors:  R Hori; M Hirai; T Katsura; M Takano; M Yasuhara; S Kaneko; M Satoh
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

10.  Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney.

Authors:  Christopher S Lepsy; Robert J Guttendorf; Alan R Kugler; David E Smith
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.